A therapeutic strategy in which short RNAs work as chaperones that bind to TDP-43 (opens in new tab)
A therapeutic strategy in which short RNAs work as chaperones that bind to and inhibit TDP-43 aggregation. These RNAs bind to TDP-43’s RNA recognition motifs, stabilizing the protein and preventing...
Read the original article